Combined Naltrexone and Bupropion Effects on Methamphetamine Use and Cigarette Smoking

Principal Investigator: Jin Yoon, PhD

Study Contact

Name: Jin Yoon

Phone Number: 713-486-2800

This study is currently looking for people who:

  • Are 18 years or older
  • Can speak and read English
  • Use methamphetamine
  • Report regular cigarette smoking

Study Description:

The purpose of this study is to investigate the effects of naltrexone-bupropion combination pharmacotherapy on smoking behavior and METH use, to test efficacy, and examine drug craving and reward mechanisms.

Bupropion is an active ingredient as some antidepressant medications and a medication used to help people stop smoking. Naltrexone-bupropion (brand name Contrave) has been shown to aid in weight loss when combined with a reduced calorie diet and exercise plan.

All participants will be compensated for their time.